An important
aspect of the Directive for both exporting nations (3rd countries) and
importing nations (European Union Member States) requires recognition
of the fact that some of the listed diseases are considered
‘exotic’ to the European Union (EU) whilst others, with limited or
widespread distribution within Member States are deemed ‘nonexotic’
(Stentiford et al., 2010).